Israel Englander Compass Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 433,755 shares of CMPX stock, worth $793,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
433,755
Previous 193,767
123.85%
Holding current value
$793,771
Previous $383,000
13.05%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CMPX
# of Institutions
84Shares Held
92.7MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$40.9 Million0.54% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$20.4 Million0.02% of portfolio
-
Blackstone Inc New York, NY7.69MShares$14.1 Million0.03% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$12.1 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.51MShares$10.1 Million0.17% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $185M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...